FDA Approves First Targeted Therapeutic Based on Tumor Biomarker, Not Tumor Origin
On Monday, the U.S. Food and Drug Administration (FDA) announced the highly anticipated approval of the molecularly targeted therapeutic...
Category: Policy
On Monday, the U.S. Food and Drug Administration (FDA) announced the highly anticipated approval of the molecularly targeted therapeutic...
During the early part of November, we saw the U.S. Food and Drug Administration (FDA) approve a new molecularly...
Thanks to decades of cancer research that have brought us groundbreaking discoveries and treatments, 15.5 million U.S. cancer survivors...
In the midst of Breast Cancer Awareness Month, the US. Food and Drug Administration (FDA) provided good news for...
Last week saw a flurry of new anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) for...
In 2017, electronic cigarettes (e-cigarettes) were the most commonly used tobacco product among high and middle school students. Many...
In the midst of the dog days of summer, the U.S. Food and Drug Administration (FDA) has provided good...
During the early part of summer 2018, the U.S. Food and Drug Administration (FDA) has approved several new anticancer...
Policymakers, parents, teachers, and public health professionals have all expressed concern about the rise in teen vaping and a...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which pembrolizumab...